Non-CME Corporate Forum sponsored by Blueprint Medicines.

Dinner will be provided.

Target Audience

The design of this activity addresses the needs of clinical immunologists, allergists, dermatologists, gastroenterologists and hematology/oncology clinicians and other healthcare professionals who manage patients with nonadvanced systemic mastocytosis (SM).

Program Overview

Nonadvanced SM is a rare, often misdiagnosed condition associated with high symptom burden and significant quality-of-life impact. This interactive program features a didactic overview of pathophysiology, diagnosis, and evolving treatment strategies of nonadvanced SM, followed by a fun and engaging Medical Jeopardy™-style game to reinforce key concepts.

Learning Objectives

After completing this activity, the participant should be better able to:

• Explain the underlying causes and effects of nonadvanced SM, with an emphasis on its clinical manifestations and the pathophysiological basis for targeted therapies

• Differentiate SM, including indolent forms, by recognizing key symptoms and appropriately utilizing laboratory and genetic testing

• Summarize clinical trial findings for emerging and established therapies, including FDA-approved treatments

• Tailor treatment plans for nonadvanced SM by incorporating clinical evidence, safety considerations, patient-reported outcomes, shared decision-making, and patient education

Americans With Disabilities Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact us prior to the live event at info@exchangecme.com.

Contact Information

For questions about this activity, please contact us at info@exchangecme.com.

Disclosure of Unlabeled Use

This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integritas does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Prefer to participate online? Register for our live stream at ExchangeCME.com/SMOrlandoLiveStream.